BICYCLE THERAPEUTICS PLC's ticker is BCYC and the CUSIP is 088786108. A total of 107 filers reported holding BICYCLE THERAPEUTICS PLC in Q2 2024. The put-call ratio across all filers is 3.65 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $11,577,280 | – | 572,000 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ridgeback Capital Investments L.P. | 2,264,801 | $67,038,110 | 80.44% |
| Sio Capital Management, LLC | 683,425 | $20,229,380 | 7.48% |
| Logos Global Management LP | 1,435,000 | $42,476,000 | 4.98% |
| Paradigm Biocapital Advisors LP | 1,233,280 | $36,505,088 | 4.28% |
| Deep Track Capital, LP | 2,819,045 | $83,443,732 | 3.50% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 905,722 | $26,809,371 | 2.67% |
| First Light Asset Management, LLC | 696,432 | $20,614,387 | 1.91% |
| HighVista Strategies LLC | 92,434 | $2,736,046 | 1.62% |
| Soleus Capital Management, L.P. | 258,400 | $7,648,640 | 1.10% |
| DAFNA Capital Management LLC | 122,200 | $3,617,120 | 1.02% |